erythromycin

erythromycin is a lipid of Polyketides (PK) class. Erythromycin is associated with abnormalities such as Systemic Inflammatory Response Syndrome, Pneumonia, Infection, Pneumococcal Infections and Exanthema. The involved functions are known as Pharmacodynamics, Sterility, Agent, Drug Kinetics and Adjudication. Erythromycin often locates in Blood, peritoneal, Extracellular, Ribosomes and apicoplast. The associated genes with erythromycin are P4HTM gene, SLC33A1 gene, FAM3B gene, Operon and Homologous Gene. The related lipids are Hydroxytestosterones, Steroids, Propionate, Mycolic Acids and campesterol. The related experimental models are Mouse Model and Knock-out.

Cross Reference

Introduction

To understand associated biological information of erythromycin, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with erythromycin?

erythromycin is suspected in Pneumonia, Infection, Gonorrhea, Cystic Fibrosis, Respiratory Tract Infections, Influenza and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with erythromycin

MeSH term MeSH ID Detail
Labyrinth Diseases D007759 3 associated lipids
Weight Gain D015430 101 associated lipids
Cardiovascular Diseases D002318 24 associated lipids
Abnormalities, Drug-Induced D000014 10 associated lipids
Abnormalities, Multiple D000015 13 associated lipids
Hypersensitivity, Delayed D006968 43 associated lipids
Endocarditis, Bacterial D004697 5 associated lipids
Staphylococcal Infections D013203 15 associated lipids
Cell Transformation, Neoplastic D002471 126 associated lipids
Leukemia P388 D007941 43 associated lipids
Per page 10 20 50 100 | Total 442

PubChem Associated disorders and diseases

What pathways are associated with erythromycin

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with erythromycin?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with erythromycin?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with erythromycin?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with erythromycin?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with erythromycin?

Mouse Model

Mouse Model are used in the study 'In vitro and in vivo activities of macrolide derivatives against Mycobacterium tuberculosis.' (Falzari K et al., 2005) and Mouse Model are used in the study 'Activity of ABT-773 against Mycobacterium avium complex in the beige mouse model.' (Cynamon MH et al., 2000).

Knock-out

Knock-out are used in the study 'Functional expression and comparative characterization of nine murine cytochromes P450 by fluorescent inhibition screening.' (McLaughlin LA et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with erythromycin

Download all related citations
Per page 10 20 50 100 | Total 13660
Authors Title Published Journal PubMed Link
Sakatis MZ et al. Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds. 2012 Chem. Res. Toxicol. pmid:22931300
Li SL et al. A single tube modified allele-specific-PCR for rapid detection of erythromycin-resistant Mycoplasma pneumoniae in Beijing. 2012 Chin. Med. J. pmid:22931973
Waśko A et al. Genetic mechanisms of variation in erythromycin resistance in Lactobacillus rhamnosus strains. 2012 J. Antibiot. pmid:22948255
Counsell H An abdominal mass in a 4-year-old child. 2012 BMJ Case Rep pmid:22922923
Juntunen P et al. Campylobacter coli isolates from Finnish farrowing farms using aminopenicillins: high prevalence of bla(OXA-61) and β-lactamase production, but low MIC values. 2012 Foodborne Pathog. Dis. pmid:22924522
Kwiatkowska B and Maślińska M Macrolide therapy in chronic inflammatory diseases. 2012 Mediators Inflamm. pmid:22969171
Leyden JJ In vivo antibacterial effects of tretinoin-clindamycin and clindamycin alone on Propionibacterium acnes with varying clindamycin minimum inhibitory. 2012 J Drugs Dermatol pmid:23377513
Hess TM and Chew HF Successful treatment of acute ocular involvement in Stevens-Johnson syndrome with amniotic membrane transplantation: a case report. 2012 Can. J. Ophthalmol. pmid:23217513
Fazeli M et al. Erythromycin enhances abomasal emptying in healthy unweaned lambs as shown by acetaminophen absorption test. 2012 J. Vet. Pharmacol. Ther. pmid:22066489
Villaseñor-Sierra A et al. Phenotypes and genotypes of erythromycin-resistant Streptococcus pyogenes strains isolated from invasive and non-invasive infections from Mexico and the USA during 1999-2010. 2012 Int. J. Infect. Dis. pmid:22217469
Luangtongkum T et al. Impaired fitness and transmission of macrolide-resistant Campylobacter jejuni in its natural host. 2012 Antimicrob. Agents Chemother. pmid:22183170
Soeters HM et al. Trimethoprim-sulfamethoxazole prophylaxis and antibiotic nonsusceptibility in invasive pneumococcal disease. 2012 Antimicrob. Agents Chemother. pmid:22232291
Sunkara B et al. Group B Streptococcus infections in non-pregnant adults: the role of immunosuppression. 2012 Int. J. Infect. Dis. pmid:22236484
Mansouri-najand L et al. Prevalence of multidrug resistance Campylobacter jejuni and Campylobacter coli in chickens slaughtered in selected markets, Malaysia. 2012 Trop Biomed pmid:22735845
Janssen BD et al. Analysis of aminoacyl- and peptidyl-tRNAs by gel electrophoresis. 2012 Methods Mol. Biol. pmid:22736012
LeTourneau N et al. Synthesis and antibacterial activity of desosamine-modified macrolide derivatives. 2012 Bioorg. Med. Chem. Lett. pmid:22738632
Harvey CJ et al. Precursor directed biosynthesis of an orthogonally functional erythromycin analogue: selectivity in the ribosome macrolide binding pocket. 2012 J. Am. Chem. Soc. pmid:22741553
Shi JG et al. The effect of CYP3A4 inhibition or induction on the pharmacokinetics and pharmacodynamics of orally administered ruxolitinib (INCB018424 phosphate) in healthy volunteers. 2012 J Clin Pharmacol pmid:21602517
Gokmen T et al. A controlled trial of erythromycin and UDCA in premature infants during parenteral nutrition in minimizing feeding intolerance and liver function abnormalities. 2012 J Perinatol pmid:21566568
Wormser GP et al. Failure of topical antibiotics to prevent disseminated Borrelia burgdorferi infection following a tick bite in C3H/HeJ mice. 2012 J. Infect. Dis. pmid:21930606
Kanazu T et al. Investigation of drug-drug interaction via mechanism-based inhibition of cytochrome P450 3A by macrolides in dexamethasone-treated female rats. 2012 Biopharm Drug Dispos pmid:22447511
Liu X et al. Potentials and mechanisms of genotoxicity of six pharmaceuticals frequently detected in freshwater environment. 2012 Toxicol. Lett. pmid:22450446
Rahube TO and Yost CK Characterization of a mobile and multiple resistance plasmid isolated from swine manure and its detection in soil after manure application. 2012 J. Appl. Microbiol. pmid:22486928
Campelo FA et al. [Phenotypes and mechanisms of resistance to macrolides and lincosamides in Streptococcus agalactiae isolates with clinical significance in an eight-year period (2002-2010)]. 2012 Rev Esp Quimioter pmid:22488541
Imai Y et al. Development of the ability to produce secondary metabolites in Streptomyces through the acquisition of erythromycin resistance. 2012 J. Antibiot. pmid:22491137
Hellmann-Regen J et al. Retinoic acid as target for local pharmacokinetic interaction with modafinil in neural cells. 2012 Eur Arch Psychiatry Clin Neurosci pmid:22434147
Vendrell D et al. Accumulation and depletion kinetics of erythromycin in rainbow trout (Oncorhynchus mykiss). 2012 Prev. Vet. Med. pmid:22436556
Peano C et al. Comparative genomics and transcriptional profiles of Saccharopolyspora erythraea NRRL 2338 and a classically improved erythromycin over-producing strain. 2012 Microb. Cell Fact. pmid:22401291
Chen CM Erythromycin for the treatment of feeding intolerance in preterm infants. 2012 Pediatr Neonatol pmid:22348487
Ng YY et al. Efficacy of intermediate-dose oral erythromycin on very low birth weight infants with feeding intolerance. 2012 Pediatr Neonatol pmid:22348492
Yoon SB et al. The effect of exenatide and erythromycin on postprandial symptoms and their relation to gastric functions. 2012 Digestion pmid:22354133
Golparian D et al. In vitro activity of the new fluoroketolide solithromycin (CEM-101) against a large collection of clinical Neisseria gonorrhoeae isolates and international reference strains, including those with high-level antimicrobial resistance: potential treatment option for gonorrhea? 2012 Antimicrob. Agents Chemother. pmid:22354296
Devlin MJ et al. Gastric emptying and symptoms of bulimia nervosa: effect of a prokinetic agent. 2012 Physiol. Behav. pmid:22361261
Chini P et al. Effect of azithromycin on small bowel motility in patients with gastrointestinal dysmotility. 2012 Scand. J. Gastroenterol. pmid:22364597
Gazzola S et al. Assessment of tetracycline and erythromycin resistance transfer during sausage fermentation by culture-dependent and -independent methods. 2012 Food Microbiol. pmid:22365347
Michael M et al. Docetaxel pharmacokinetics and its correlation with two in vivo probes for cytochrome P450 enzymes: the C(14)-erythromycin breath test and the antipyrine clearance test. 2012 Cancer Chemother. Pharmacol. pmid:21626050
Chhun S et al. The cytochrome P-450 2C9/2C19 but not the ABCB1 genetic polymorphism may be associated with the liver cytochrome 3A4 induction by phenytoin. 2012 J Clin Psychopharmacol pmid:22561479
Ohene-Agyei T et al. Mutations in MexB that affect the efflux of antibiotics with cytoplasmic targets. 2012 FEMS Microbiol. Lett. pmid:22568688
Chen C et al. Isolation and characterization of LS1924A, a new analog of emycins. 2012 J. Antibiot. pmid:22569162
Mandisodza O et al. Arcobacter species in diarrhoeal faeces from humans in New Zealand. 2012 N. Z. Med. J. pmid:22522270
Gao J et al. Antibiotic resistance of Streptococcus agalactiae from cows with mastitis. 2012 Vet. J. pmid:22627045
He JL et al. [Distribution of anaerobes in periodontal abscess and its resistance to antibiotics]. 2012 Zhonghua Kou Qiang Yi Xue Za Zhi pmid:23328096
Leung HW et al. Distribution, fate and risk assessment of antibiotics in sewage treatment plants in Hong Kong, South China. 2012 Environ Int pmid:21450345
Giovanetti E et al. ICESp2905, the erm(TR)-tet(O) element of Streptococcus pyogenes, is formed by two independent integrative and conjugative elements. 2012 Antimicrob. Agents Chemother. pmid:21986826
Du Plessis LH et al. In vitro activity of Pheroid vesicles containing antibiotics against Plasmodium falciparum. 2012 J. Antibiot. pmid:23093037
Brenciani A et al. ICESp1116, the genetic element responsible for erm(B)-mediated, inducible resistance to erythromycin in Streptococcus pyogenes. 2012 Antimicrob. Agents Chemother. pmid:23027190
PiÄ…tkowska E et al. The strongest resistance of Staphylococcus aureus to erythromycin is caused by decreasing uptake of the antibiotic into the cells. 2012 Cell. Mol. Biol. Lett. pmid:23001512
Leiding JW et al. Successful sirolimus graded dose challenge in an erythromycin-allergic patient. 2012 Ann. Allergy Asthma Immunol. pmid:23010239
Brill S et al. Transforming a drug/H+ antiporter into a polyamine importer by a single mutation. 2012 Proc. Natl. Acad. Sci. U.S.A. pmid:23035252
Kou X et al. Synthesis, characterization and adsorption behavior of molecularly imprinted nanospheres for erythromycin using precipitation polymerization. 2012 J Nanosci Nanotechnol pmid:23035481